Guido A. Baselli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.
Journal: EMBO molecular medicine
Published: March 13, 2026
SOX21 suppresses glioblastoma growth by repressing AP-1 activity.
Journal: Cell death & disease
Published: July 14, 2025
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Journal: Nature medicine
Published: January 24, 2024
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Journal: Journal of hepatology
Published: December 08, 2022
Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiers.
Journal: Journal of hepatology
Published: July 21, 2022
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
Journal: EMBO molecular medicine
Published: April 29, 2022
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.
Journal: Science translational medicine
Published: March 23, 2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
Journal: Human molecular genetics
Published: January 14, 2022
PSD3 downregulation confers protection against fatty liver disease.
Journal: Nature metabolism
Published: August 23, 2021
Last Updated: 09/26/2026